P44. Activin A is novel circulating biomarker in lung cancer

BACKGROUND: Therapeutic decision making for the treatment of lung cancer is often a complex and challenging task. Biomarkers are urgently needed that can facilitate the early detection of these malignant diseases and can predict which therapeutic modality can significantly contribute to tumor contro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Lung Cancer Res
Asıl Yazarlar: Rozsas, Anita, Hoda, Mir Alireza, Klikovits, Thomas, Schlech, Karin, Laszlo, Viktoria, Grusch, Michael, Berger, Walter, Klepetko, Walter, Hegedus, Balazs, Dome, Balazs
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Pioneer Bioscience Publishing Company 2014
Konular:
CELCC 2014 Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367750/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB056
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller